Test offers improved diagnosis and treatment of reflux disease.
6-Apr-2015 9:00 AM EDT
Scott & White Hospital – Round Rock, a hospital within Baylor Scott & White Health, is the first hospital in the Central Texas region to perform a same-day joint replacement discharge on a patient who underwent a direct anterior total hip...
2-Apr-2015 12:35 PM EDT
A new Headache Clinic has opened at Scott & White Clinic - Round Rock, a part of Baylor Scott & White Health, serving patients in the Central Texas area including Austin and Round Rock.
1-Apr-2015 10:15 AM EDT
A new study developed at Baylor Research Institute at Dallas has discovered unique microRNA signatures in primary colorectal cancers that could predict metastasis in the distant future.
29-Jan-2015 2:50 PM EST
It’s very difficult to understand the retinal structure of children because they are known to be uncooperative during eye examinations designed for adults. Baylor research, published in JAMA Ophthalmology, explores a new non-invasive technology...
22-Jan-2015 12:00 PM EST
Baylor Research Institute investigators found that the lipoprotein LOX-1 promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections.
10-Dec-2014 2:00 PM EST
Baylor Research Institute Enters License Agreement for Anakinra in Treating Systemic Onset Juvenile Idiopathic Arthritis
Baylor Research Institute (BRI), the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor’s patents pertaining to the treatment of...
5-Dec-2014 1:00 PM EST
Baylor Scott & White Health Celebrates American Diabetes Month® with First Long-Term Trial Comparing Type 2 Diabetes Treatments
Despite the availability of many medications, doctors have very little information about the best way to treat diabetes. However, a new study involving Baylor’s endocrinology team could give more insights and provide better options for diabetes...
24-Nov-2014 6:00 AM EST
The European Medicines Agency (EMA), the equivalent of the U.S. Food and Drug Administration, has approved the use of the hollow fiber system for the development of drugs to treat and prevent tuberculosis (TB). The hollow fiber system model of TB...
23-Mar-2015 2:05 PM EDT